BIOL
Biolase, Inc.
BIOL
BIOL
Delisted
BIOL was delisted on the 18th of June, 2024.
24 hedge funds and large institutions have $3.59M invested in Biolase, Inc. in 2022 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 8 increasing their positions, 3 reducing their positions, and 1 closing their positions.
Holders
24
Holders Change
-1
Holders Change %
-4%
% of All Funds
0.42%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
8
Reduced
3
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
1
Morgan Stanley
New York
|
$21K |
| 2 |
2
Citadel Advisors
Miami,
Florida
|
$43K |
| 3 |
3
BlackRock
New York
|
$302K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
26
Fidelity Investments
Boston,
Massachusetts
| $0 | 41 | +41 | New |
|